Boston Scientific Corp

BSX: XNYS (USA)
View Stock Summary
Morningstar Rating for StocksFair ValueEconomic MoatCapital Allocation
BKLOCK|?xw<sLOCK|q<pw@k$

Boston Scientific Earnings: Competitive Pressure Closing in on Key Growth Areas

Boston reported second-quarter results that included revenue of $5.44 billion (up 7% operationally) and net income of $905 million (up 14% year over year), along with a lower outlook for the full year.

Sponsor Center